• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Eloxx Pharmaceuticals, Inc. - Common Stock (NQ:ELOX)

    19.18 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 19.18
    Bid (Size) 16.55 (200)
    Ask (Size) 25.00 (100)
    Prev. Close 19.18
    Today's Range 19.18 - 19.18
    52wk Range 8.200 - 19.96
    Shares Outstanding 2,752,774
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
    From Eloxx Pharmaceuticals
    Via GlobeNewswire

    Performance

    YTD
    +74.2%
    +74.2%
    1 Month
    +69.0%
    +69.0%
    3 Month
    +74.2%
    +74.2%
    6 Month
    +74.2%
    +74.2%
    1 Year
    +74.2%
    +74.2%

    More News

    Read More
    News headline image
    Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor ↗
    Via InvestorPlace
    News headline image
    Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) Near the Top of Equities by Percentage Gain on 8/30
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Eloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eloxx Pharmaceuticals Reports Independent Confirmation of Positive Biopsy Results in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
    Via Benzinga
    News headline image
    Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Eloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement
    From Eloxx Pharmaceuticals
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Via Benzinga
    News headline image
    Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
    Via Benzinga
    News headline image
    This Small Cap Stock Surged Over 100%
    Via MarketBeat
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    Via InvestorPlace

    Frequently Asked Questions

    Is Eloxx Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Eloxx Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Eloxx Pharmaceuticals, Inc. - Common Stock trade on?
    Eloxx Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Eloxx Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Eloxx Pharmaceuticals, Inc. - Common Stock is ELOX on the Nasdaq Stock Market
    What is the current price of Eloxx Pharmaceuticals, Inc. - Common Stock?
    The current price of Eloxx Pharmaceuticals, Inc. - Common Stock is 19.18
    When was Eloxx Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Eloxx Pharmaceuticals, Inc. - Common Stock was at 08/11/26 04:00 PM ET
    What is the market capitalization of Eloxx Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Eloxx Pharmaceuticals, Inc. - Common Stock is 52.80M
    How many shares of Eloxx Pharmaceuticals, Inc. - Common Stock are outstanding?
    Eloxx Pharmaceuticals, Inc. - Common Stock has 53M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.